Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification.
Xiaowei Li,Wenhua Zhu,Meiyang Fan,Jing Zhang,Yizhao Peng,Fumeng Huang,Nan Wang,Langchong He,Lei Zhang,Rikard Holmdahl,Liesu Meng,Shemin Lu +11 more
Reads0
Chats0
TLDR
In this article, the authors used SARS-CoV-2 pseudoviruses to infect human angiotensin-converting enzyme 2 (ACE2) expressing HEK293T cells and evaluated virus infection.Abstract:
Coronavirus disease 2019 is a kind of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) However, the mechanism whereby SARS-CoV-2 invades host cells remains poorly understood Here we used SARS-CoV-2 pseudoviruses to infect human angiotensin-converting enzyme 2 (ACE2) expressing HEK293T cells and evaluated virus infection We confirmed that SARS-CoV-2 entry was dependent on ACE2 and sensitive to pH of endosome/lysosome in HEK293T cells The infection of SARS-CoV-2 pseudoviruses is independent of dynamin, clathrin, caveolin and endophilin A2, as well as macropinocytosis Instead, we found that the infection of SARS-CoV-2 pseudoviruses was cholesterol-rich lipid raft dependent Cholesterol depletion of cell membranes with methyl-β-cyclodextrin resulted in reduction of pseudovirus infection The infection of SARS-CoV-2 pseudoviruses resumed with cholesterol supplementation Together, cholesterol-rich lipid rafts, and endosomal acidification, are key steps of SARS-CoV-2 required for infection of host cells Therefore, our finding expands the understanding of SARS-CoV-2 entry mechanism and provides a new anti-SARS-CoV-2 strategyread more
Citations
More filters
Journal ArticleDOI
Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases.
TL;DR: In this article, the effects of excess cholesterol on disease pathogenesis, including liver diseases, diabetes, chronic kidney disease, Alzheimer's disease, osteoporosis, osteoarthritis, pituitary-thyroid axis dysfunction, immune disorders, and COVID-19, were summarized.
Journal ArticleDOI
Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections
TL;DR: In this paper , the authors focus on five major metabolic pathways including glycolysis, pentose phosphate pathway, fatty acid oxidation and synthesis, tricarboxylic acid cycle and amino acid metabolism and discuss how they sustain and regulate macrophage immune function in response to parasitic, bacterial and viral infections as well as trained immunity.
Journal ArticleDOI
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Lívia Teixeira,Jairo R. Temerozo,Filipe S. Pereira-Dutra,André C. Ferreira,Mayara Mattos,Barbara Simonson Gonçalves,Carolina Q. Sacramento,Lohanna Palhinha,Tamires Cunha-Fernandes,Suelen da Silva Gomes Dias,Vinicius Cardoso Soares,Ester A. Barreto,Daniella Cesar-Silva,Natalia Fintelman-Rodrigues,Camila R. R. Pão,Caroline S. de Freitas,Patrícia A. Reis,Eugenio D. Hottz,Fernando A. Bozza,Dumith Chequer Bou-Habib,Elvira M. Saraiva,Cecilia J. de Almeida,João P. B. Viola,Thiago Moreno L. Souza,Patrícia T. Bozza +24 more
TL;DR: Results show that simvastatin exhibits early protective effects on SARS-CoV-2 infection by inhibiting virus cell entry and inflammatory cytokine production, through mechanisms at least in part dependent on lipid rafts disruption.
Journal ArticleDOI
Good Cholesterol Gone Bad? HDL and COVID-19.
TL;DR: In this paper, the authors reviewed the complex role of HDL and SR-B1 in SARS-CoV-2-induced disease and showed that the ability of HDL to enhance or suppress virus infection appears to be dependent on the expression of the HDL receptor in the target cells.
Journal ArticleDOI
Coronavirus Infection and Cholesterol Metabolism
Jun Dai,Huanting Wang,Ying Liao,Lei Tan,Yingjie Sun,Cuiping Song,Weiwei Liu,Xusheng Qiu,Chan Ding +8 more
TL;DR: This review comprehensively review the literature to clarify how coronaviruses exploit host cholesterol metabolism to accommodate viral replication requirements and interfere with host immune responses and focuses on targeting cholesterol homeostasis to interfere with critical steps during coronavirus infection.
References
More filters
Journal ArticleDOI
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou,Xing-Lou Yang,Xian Guang Wang,Ben Hu,Lei Zhang,Wei Zhang,Hao Rui Si,Yan Zhu,Bei Li,Chao Lin Huang,Hui-Dong Chen,Jing Chen,Yun Luo,Hua Guo,Ren Di Jiang,Meiqin Liu,Ying Chen,Xu Rui Shen,Xi Wang,Xiao Shuang Zheng,Kai Zhao,Quanjiao Chen,Fei Deng,Lin Lin Liu,Bing Yan,Fa Xian Zhan,Yan-Yi Wang,Gengfu Xiao,Zhengli Shi +28 more
TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann,Hannah Kleine-Weber,Simon Schroeder,Nadine Krüger,Tanja Herrler,Sandra Erichsen,Tobias S. Schiergens,Georg Herrler,Nai Huei Wu,Andreas Nitsche,Marcel A. Müller,Christian Drosten,Christian Drosten,Stefan Pöhlmann +13 more
TL;DR: It is demonstrated that SARS-CoV-2 uses the SARS -CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross-neutralized Sars-2-S-driven entry.
Journal ArticleDOI
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu,Jennifer M. McGoogan +1 more
TL;DR: Hospitalised COVID-19 patients are frequently elderly subjects with co-morbidities receiving polypharmacy, all of which are known risk factors for d
Journal ArticleDOI
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Alexandra C. Walls,Young-Jun Park,M. Alejandra Tortorici,M. Alejandra Tortorici,Abigail Wall,Andrew T. McGuire,Andrew T. McGuire,David Veesler +7 more
TL;DR: It is demonstrating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination, and it is shown that SARS-CoV-2 S uses ACE2 to enter cells and that the receptor-binding domains of Sars- coV- 2 S and SARS S bind with similar affinities to human ACE2, correlating with the efficient spread of SATS among humans.
Journal ArticleDOI
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang,Ruiyuan Cao,Leike Zhang,Xing-Lou Yang,Jia Liu,Mingyue Xu,Zhengli Shi,Zhihong Hu,Wu Zhong,Gengfu Xiao +9 more
TL;DR: This study evaluated the antiviral efficiency of five FAD-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine and two well-known broad-spectrum antiviral drugs remdesivir and favipiravir against a clinical isolate of 2019-nCoV in vitro.
Related Papers (5)
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.
Suelen da Silva Gomes Dias,Vinicius Cardoso Soares,Vinicius Cardoso Soares,André C. Ferreira,Carolina Q. Sacramento,Natalia Fintelman-Rodrigues,Jairo R. Temerozo,Lívia Teixeira,Marcos Alexandre Nunes da Silva,Ester A. Barreto,Mayara Mattos,Caroline S. de Freitas,Isaclaudia G. de Azevedo-Quintanilha,Pedro P.A. Manso,Milene D. Miranda,Marilda M. Siqueira,Eugenio D. Hottz,Eugenio D. Hottz,Camila R. R. Pão,Dumith Chequer Bou-Habib,Debora Ferreira Barreto-Vieira,Fernando A. Bozza,Thiago Moreno L. Souza,Patrícia T. Bozza +23 more